BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35290637)

  • 21. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-redundancy of cytidine deaminases in class switch recombination.
    Fugmann SD; Rush JS; Schatz DG
    Eur J Immunol; 2004 Mar; 34(3):844-849. PubMed ID: 14991614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation.
    Nabel CS; Jia H; Ye Y; Shen L; Goldschmidt HL; Stivers JT; Zhang Y; Kohli RM
    Nat Chem Biol; 2012 Sep; 8(9):751-8. PubMed ID: 22772155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reward versus risk: DNA cytidine deaminases triggering immunity and disease.
    Pham P; Bransteitter R; Goodman MF
    Biochemistry; 2005 Mar; 44(8):2703-15. PubMed ID: 15723516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of base editors with anti-deaminases derived from viruses.
    Liu Z; Chen S; Lai L; Li Z
    Nat Commun; 2022 Feb; 13(1):597. PubMed ID: 35105899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.
    McGrath E; Shin H; Zhang L; Phue JN; Wu WW; Shen RF; Jang YY; Revollo J; Ye Z
    Nat Commun; 2019 Nov; 10(1):5353. PubMed ID: 31767844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
    Knisbacher BA; Gerber D; Levanon EY
    Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
    Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
    PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Insights Into the Lineage-Specific Expansion and Functional Diversification of Lamprey AID/APOBEC Family.
    Chen Y; Luo L; Deng L; Tian X; Chen S; Xu A; Yuan S
    Front Immunol; 2022; 13():822616. PubMed ID: 35359986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming.
    Morgan HD; Dean W; Coker HA; Reik W; Petersen-Mahrt SK
    J Biol Chem; 2004 Dec; 279(50):52353-60. PubMed ID: 15448152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genes.
    Chen J; MacCarthy T
    PLoS Comput Biol; 2017 Mar; 13(3):e1005471. PubMed ID: 28362825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase.
    Anant S; Yu H; Davidson NO
    Biol Chem; 1998; 379(8-9):1075-81. PubMed ID: 9792440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
    Shi MJ; Meng XY; Lamy P; Banday AR; Yang J; Moreno-Vega A; Chen CL; Dyrskjøt L; Bernard-Pierrot I; Prokunina-Olsson L; Radvanyi F
    Eur Urol; 2019 Jul; 76(1):9-13. PubMed ID: 30975452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes.
    Lada AG; Kliver SF; Dhar A; Polev DE; Masharsky AE; Rogozin IB; Pavlov YI
    PLoS Genet; 2015 May; 11(5):e1005217. PubMed ID: 25941824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
    Bishop KN; Holmes RK; Malim MH
    J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
    Love RP; Xu H; Chelico L
    J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
    Steele EJ
    DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
    Xie K; Sowden MP; Dance GS; Torelli AT; Smith HC; Wedekind JE
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8114-9. PubMed ID: 15148397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.